Perhaps due to the loss of tumor weight, the CGL1 treatment group showed a significant decrease in body weight from the 8th day compared with the control of HCT116-bearing models (Figure 6C, p < 0.001 or p < 0.01). This evidence concerns the gene GZMB and neoplasm.